We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLM
2726
DELISTED
PolyMet Mining Corp.
PLM
$32K ﹤0.01%
+4,520
New +$43.5K
ZNB
2727
Zeta Network Group
ZNB
$64.9K
0
TIGR
2728
DELISTED
TIGERLOGIC CORPORATION COM STK (DE)
TIGR
$30K ﹤0.01%
+17,200
New +$31.3K
ATL
2729
DELISTED
ATLATSA RES CORP RESOURCES CORP (F)
ATL
$27K ﹤0.01%
+130,900
New +$26.4K
ASTI
2730
DELISTED
ASCENT SOLAR TECHNOLOGIES INC COM STK
ASTI
$26K ﹤0.01%
+3,362
New +$22.8K
TELK
2731
DELISTED
TELIK, INC
TELK
$25K ﹤0.01%
+18,252
New +$24.8K
CHTP
2732
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
$24K ﹤0.01%
+10,394
New +$21K
SGLY icon
2733
Singularity Future Technology
SGLY
$241K
$22K ﹤0.01%
+22
New +$23.5K
SDEV
2734
Stablecoin Development Corp
SDEV
$29.8M
0
AIM
2735
AIM ImmunoTech
AIM
$6.9M
$21K ﹤0.01%
+2
New +$23.9K
CASM
2736
DELISTED
CAS Medical Systems, Inc.
CASM
$20K ﹤0.01%
+12,200
New +$22.6K
VSCP
2737
DELISTED
VIRTUALSCOPICS INC COM NEW
VSCP
$20K ﹤0.01%
+5,300
New +$29.8K
ORKA
2738
Oruka Therapeutics
ORKA
$5.56B
$19K ﹤0.01%
+10
New +$30.5K
WINT
2739
DELISTED
Windtree Therapeutics Inc
WINT
$19K ﹤0.01%
+885
New +$21.8K
MBIS
2740
DELISTED
MEDIABISTRO INC COM (DE)
MBIS
$19K ﹤0.01%
+11,741
New +$17.2K
DLHC icon
2741
DLH Holdings
DLHC
$73.8M
$18K ﹤0.01%
+21,975
New +$18.8K
INVE icon
2742
Identive
INVE
$64.6M
$18K ﹤0.01%
+2,440
New +$23.3K
AMCF
2743
DELISTED
ANDATEE CHINA MARINE FUEL SVCS CORP COM STK (DE)
AMCF
$18K ﹤0.01%
+32,900
New +$21.3K
SPPR
2744
DELISTED
SUPERTEL HOSPITALITY, INC. COM NEW (MD)
SPPR
$17K ﹤0.01%
+2,175
New +$18.1K
OSN
2745
DELISTED
Ossen Innovation Co., Ltd.
OSN
$14K ﹤0.01%
+6,733
New +$14.6K
SPIR
2746
DELISTED
SPIRE CORP
SPIR
$14K ﹤0.01%
+24,500
New +$15K
CREG
2747
DELISTED
Smart Powerr
CREG
$13K ﹤0.01%
+1
New +$10K
SSN
2748
DELISTED
Samson Oil & Gas Limited
SSN
$12K ﹤0.01%
+2,842
New +$13.6K
NLST
2749
DELISTED
Netlist, Inc.
NLST
$10K ﹤0.01%
+10,900
New +$7.63K
GNVC
2750
DELISTED
GenVec, Inc.
GNVC
$8K ﹤0.01%
+2,250
New +$19K

Similar funds

Renaissance Technologies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.